Chemotherapy toxicity trang 1 tải miễn phí từ TAILIEUCHUNG

"Chemotherapy toxicity" trang 1 - tải miễn phí từ Tailieuchung

Low lean mass and chemotherapy toxicity risk in the elderly: The Fraction study protocol

Low lean mass and chemotherapy toxicity risk in the elderly: The Fraction study protocol

8 59 0

Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neoadjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neoadjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

10 81 0

CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer

CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer

7 69 1

A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer

A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer

18 26 1

Metronomic chemotherapy with oral navelbine produces clinical benefit and low toxicity in metastatic breast cancer in K-Hospital

Metronomic chemotherapy with oral navelbine produces clinical benefit and low toxicity in metastatic breast cancer in K-Hospital

6 41 1

Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: A toxicity study

Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: A toxicity study

9 45 0

Cardio-toxicity among patients with sarcoma: A cardio-oncology registry

Cardio-toxicity among patients with sarcoma: A cardio-oncology registry

7 30 1

Association of DNA repair gene variants with colorectal cancer: Risk, toxicity, and survival

Association of DNA repair gene variants with colorectal cancer: Risk, toxicity, and survival

10 65 0

Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: A plea for multimodal immune modulating therapy in the respiratory insufficient patient

Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: A plea for multimodal immune modulating therapy in the respiratory insufficient patient

11 35 1

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy

11 81 1

Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxelbased chemotherapy in breast cancer patients

Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxelbased chemotherapy in breast cancer patients

13 44 1

Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers

Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers

9 17 1

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer

13 63 0

$Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A cohort study$

Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A cohort study

7 58 1

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer

11 90 0

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

10 61 1

Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro

Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro

11 39 1

Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: A retrospective analysis

Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: A retrospective analysis

11 22 1

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

9 47 1

Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma

Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma

9 72 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.